Connecticut CannaTimesFacts first. You decide.

CT Drug Control Director Steps Down Amid Cannabis Retaliation Scandal

Rodrick Marriott, longtime head of the Department of Consumer Protection’s Drug Control Division, has resigned just weeks after a state investigation faulted him for his role in an unauthorized inspection of a cannabis cultivator. His last day at the agency was September 2, ending a 17-year career.

By Connecticut CannaTimesPublished

Part of Public Records, FOIA and Transparency

In this storyMarriottDCP

By CT CannaTimes Editorial Board

A Sudden Departure

Rodrick Marriott, longtime head of the Department of Consumer Protection’s Drug Control Division, has resigned just weeks after a state investigation faulted him for his role in an unauthorized inspection of a cannabis cultivator. His last day at the agency was September 2, ending a 17-year career.

Marriott formally submitted his resignation letter on August 7, one day after appearing at a pre-disciplinary hearing where the maximum penalty under consideration was a five-day suspension. In his letter, Marriott made no mention of the scandal, simply thanking the agency for the opportunities provided during his tenure.

Full coverage here:

https://ctnewsjunkie.com/2025/09/16/connecticut-drug-controlation-into-surprise-inspection-of-cannabis-cultivators-facility/

Fallout for the Agency

During the investigation, Marriott was stripped of cannabis oversight duties and those responsibilities were reassigned to a separate division led by a DCP attorney. This was a clear acknowledgment from DCP leadership that trust in Marriott’s division had been compromised.

In its public statements following his departure, DCP stressed that “everyone should feel safe and comfortable providing testimony at a public hearing without fear of retribution or retaliation” and that the agency has taken “several steps toward improving communication with the cannabis industry.”

Coverage via WSHU:

https://www.wshu.org/connecticut-news/2025-09-16/ct-dcp-drug-director-named-in-unauthorized-cannabis-inspection

What Comes Next

While Marriott’s resignation may close one chapter, the damage to DCP’s credibility lingers. Operators remain wary of engaging openly with regulators, fearing that dissent could still trigger retaliation.

The department says it does “not anticipate any further issues of this nature,” but confidence in those assurances will depend on whether meaningful cultural change follows Marriott’s exit.

This story was originally published by Connecticut CannaTimes on Facebook on September 16, 2025 and was migrated to this website on October 16, 2026. The publication date above is the original date.

More in Public Records, FOIA and Transparency

The full investigation
  1. DCP Faces October 26 Deadline on Testing Transparency and Patient Oversight Petition
  2. Lamont Administration Worked on Tribal Compact for 20 Months; Industry Got 45 Minutes' Notice
  3. Connecticut Has Quietly Tested Hundreds of Cannabis Products. Now It Is Expanding Its Reference Lab